News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Scarlet Therapeutics, a leader in red blood cell-based therapeutics, has raised seed funding from Science Creates Ventures and Meltwind to develop its platform and build a pipeline of novel therapies.
Memorial Sloan Kettering Cancer Center (MSK) has announced the creation of The Marie-Josée Kravis Center for Cancer Immunobiology (CCI).
Neurimmune has announced that primary results of its phase 1 proof-of-concept study of NI006, a recombinant human antibody to deplete amyloid deposits in ATTR cardiomyopathy, have been presented in Prague at Heart Failure 2023, a scientific congress of...
Q&A with Alma Salibasic, regulatory affairs manager at ICON.